The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Dexamethasone Promotes Expression of Membrane-Bound Macrophage Colony-Stimulating Factor in Murine Osteoblast-Like Cells 1
Abstract
The mechanisms by which glucocorticosteroids promote osteoclastogenesis in vitro are uncertain. As macrophage colony-stimulating factor (MCSF) is critical for osteoclastogenesis, we hypothesized that glucocorticosteroids might regulate membrane-bound MCSF (mMCSF) and soluble MCSF (sMCSF) production by stromal cells or osteoblasts. ST2 cells or murine calvarial osteoblasts (MOBs) were treated with dexamethasone (Dex; 100 nM) and/or 1,25-dihydroxyvitamin D [1,25(OH)2D; 10 nM] for 3 days. Control values for mMCSF and sMCSF as units per 100,000 cells were 9 +/- 1.4 and 511 +/- 56 in ST2 cells and 5.9 +/- 0.8 and 379 +/- 47 in MOB cells, respectively. Dex increased mMCSF to 156 +/- 16% and 143 +/- 26% compared with the control value in ST2 and MOB cells, respectively, whereas 1,25-(OH)2D caused increases of 195 +/- 16% and 164 +/- 21%. In the presence of both Dex and 1,25-(OH)2D, mMCSF increased to 209 +/- 24% and 216 +/- 26% in the two cell types, respectively. 1,25-(OH)2D caused modest increases in sMCSF, as expected, in both cell types (153 +/- 6% and 122 +/- 4%). Dex inhibited 1,25-(OH)2D-stimulated sMCSF (115 +/- 7% of control) in ST2 cells. Analysis of mMCSF transcript levels by semiquantitative RT-PCR revealed Dex-stimulated increases of 170 +/- 11% in ST2 cells and 126 +/- 16% in MOB cells compared with the control level. The increased expression of the transcript for sMCSF in the presence of Dex and 1,25-(OH)2D, measured by both RT-PCR and Northern analysis (219 +/- 53% and 242%, respectively), despite inhibition of sMCSF protein, indicated that the inhibitory effect of Dex in ST2 cells was posttranscriptional. Half-life studies showed that Dex prolonged MCSF messenger RNA from 2.8 to 7.5 h. These results suggest that Dex influences osteoclastogenesis by increasing the expression of mMCSF by accessory cells in culture.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Glucocorticoids also stimulate osteoblasts to produce M-CSF (260), which is an important cofactor for osteoclastogenesis (261).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [260]
Citations
Cites
Modulation of Osteoclast Differentiation
Suda, T., Takahashi, N., & Martin, T. J. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-66 · Cited by 1,004
Tanaka, S., Takahashi, N., Udagawa, N., Tamura, T., Akatsu, T., Stanley, E., Kurokawa, T., & Suda, T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116179 · Cited by 594
Udagawa, N., Takahashi, N., Akatsu, T., Sasaki, T., Yamaguchi, A., KODAMA, H., Martin, T. J., & Suda, T. (1989) · Endocrinology · doi:10.1210/endo-125-4-1805 · Cited by 492
MACROPHAGE COLONY STIMULATING FACTOR RESTORESIN VIVOBONE RESORPTION IN THEOP/OPOSTEOPETROTIC MOUSE
Felix, R., Cecchini, M. G., & Fleisch, H. A. (1990) · Endocrinology · doi:10.1210/endo-127-5-2592 · Cited by 441
Udagawa, N., Takahashi, N., Katagiri, T., Tamura, T., Wada, S., Findlay, D. M., Martin, T. J., Hirota, H., Taga, T., Kishimoto, T., et al. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.5.1461 · Cited by 410
Hahn, T. J., Halstead, L. R., & Baran, D. T. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-52-1-111 · Cited by 309
Kimble, R. B., Srivastava, S., Ross, F. P., Matayoshi, A., & Pacifici, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28890 · Cited by 272
Dempster, D. W., ARLOT, M. E., & Meunier, P. J. (1983) · Calcified Tissue International · doi:10.1007/bf02405069 · Cited by 236
GOAD, D. L., Rubin, J. E., Wang, H., Tashjian, A. H., & Patterson, C. (1996) · Endocrinology · doi:10.1210/endo.137.6.8641174 · Cited by 217
Self-citationClark, R. A. F., McCoy, G. A., Folkvord, J. M., & McPherson, J. M. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199701)170:1 · Cited by 212
Self-citation
Cited by
Sorted by citations
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
CANALIS, E. M., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,131
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment
Chotiyarnwong, P., & McCloskey, E. V. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0341-0 · Cited by 489
Mechanisms of Glucocorticoid Action in Bone
CANALIS, E., & DELANY, A. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04204.x · Cited by 406
Glucocorticoids suppress bone formation via the osteoclast.
Kim, H.-J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28084 · Cited by 384
Drug-Loaded Carbon Nanohorns: Adsorption and Release of Dexamethasone in Vitro
Murakami, T., Ajima, K., Miyawaki, J., Yudasaka, M., Iijima, S., & Shiba, K. (2004) · Molecular Pharmaceutics · doi:10.1021/mp049928e · Cited by 351
Perspectives on glucocorticoid-induced osteoporosis
CANALIS, E. M., Bilezikian, J. P., Angeli, A., & Giustina, A. (2003) · Bone · doi:10.1016/j.bone.2003.11.026 · Cited by 244
Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives
Seibel, M. J., Cooper, M. S., & Zhou, H. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70045-7 · Cited by 235
Management of glucocorticoid-induced osteoporosis
Compston, J. E. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.259 · Cited by 193
Mazziotti, G., Frara, S., & Giustina, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00005 · Cited by 181
Distinct Anabolic Response of Osteoblast to Low-Intensity Pulsed Ultrasound
Naruse, K., Miyauchi, A., Itoman, M., & Mikuni‐Takagaki, Y. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.2.360 · Cited by 173
Mechanisms of glucocorticoid-induced osteoporosis.
Canalis, E. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200307000-00013 · Cited by 164
Mechanisms of glucocorticoid action in bone
CANALIS, E. M. (2005) · Current Osteoporosis Reports · doi:10.1007/s11914-005-0017-7 · Cited by 160
Pathogenic mechanisms of glucocorticoid-induced osteoporosis
Chen, M., Fu, W., Xu, H., & Liu, C.-J. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.03.002 · Cited by 146
Dai, X.-M., Zong, X.-H., Sylvestre, V. T., & Stanley, E. R. (2003) · Blood · doi:10.1182/blood-2003-08-2739 · Cited by 144
Rubin, J., Murphy, T. C., Fan, X., Goldschmidt, M., & Taylor, W. R. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.8.1452 · Cited by 131
Self-citationGlucocorticoid-Induced Osteoporosis: Summary of a Workshop
CANALIS, E. M., & Giustina, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8066 · Cited by 132
Swanson, C., Lorentzon, M., Conaway, H. H., & Lerner, U. H. (2006) · Endocrinology · doi:10.1210/en.2005-0717 · Cited by 114
The Role of CSF-1 in Normal Physiology of Mammary Gland and Breast Cancer: An Update
Sapi, E. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422900101 · Cited by 103
詫摩, 敦., Kaneda, T., Sato, T., Ninomiya, S., Kumegawa, M., & Hakeda, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300213200 · Cited by 100
Effect of corticosteroids on human osteoclast formation and activity
HIRAYAMA, T., Sabokbar, A., & Athanasou, N. A. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750155 · Cited by 99
Chronic Glucocorticoid Therapy-Induced Osteoporosis in Patients With Obstructive Lung Disease
Goldstein, M. F., Fallon, J. J., & Harning, R. (1999) · CHEST Journal · doi:10.1378/chest.116.6.1733 · Cited by 93
Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes
Gado, M., Baschant, U., Hofbauer, L. C., & Henneicke, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.835720 · Cited by 95
de Vries, T. J., Schoenmaker, T., Wattanaroonwong, N., van den Hoonaard, M., Nieuwenhuijse, A., Beertsen, W., & Everts, V. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20795 · Cited by 90
Douglass, T. G., Driggers, L., Zhang, J. G., Hoa, N. T., Delgado, C., Williams, C. C., Dan, Q., Sanchez, R., Jeffes, E. W. B., Wepsic, H. T., et al. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.04.016 · Cited by 81
Sher, L. B., Harrison, J. R., Adams, D. J., & Kream, B. E. (2006) · Calcified Tissue International · doi:10.1007/s00223-005-0297-z · Cited by 79
Pasqualetti, S., Congiu, T., Banfi, G., & Mariotti, M. (2015) · International Journal of Experimental Pathology · doi:10.1111/iep.12106 · Cited by 74
Tsubaki, M., Satou, T., Itoh, T., Imano, M., Yanae, M., Kato, C., Takagoshi, R., Komai, M., & Nishida, S. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.05.002 · Cited by 73
Bost, K. L., Bento, J. L., Ellington, J. K., Marriott, I., & Hudson, M. C. (2000) · Infection and Immunity · doi:10.1128/iai.68.9.5075-5083.2000 · Cited by 66
Endogenous Glucocorticoids and Bone
Zhou, H., Cooper, M. S., & Seibel, M. J. (2013) · Bone Research · doi:10.4248/br201302001 · Cited by 63
Psychological stress and aging: role of glucocorticoids (GCs)
Hasan, K., Rahman, M. S., Arif, K. M. T., & Sobhani, M. E. (2011) · AGE · doi:10.1007/s11357-011-9319-0 · Cited by 62
von Scheven, E., Corbin, K. J., Stagi, S., & Cimaz, R. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0228-x · Cited by 58
van der Burgh, A. C., de Keyser, C. E., Zillikens, M. C., & Stricker, B. H. C. (2021) · Drugs · doi:10.1007/s40265-021-01625-8 · Cited by 60
Conaway, H. H., Henning, P., Lie, A., Tuckermann, J. P., & Lerner, U. H. (2016) · Bone · doi:10.1016/j.bone.2016.08.024 · Cited by 57
New understanding of glucocorticoid action in bone cells
Kim, H. J. (2010) · BMB Reports · doi:10.5483/bmbrep.2010.43.8.524 · Cited by 55
Glucocorticoid-induced delayed fracture healing and impaired bone biomechanical properties in mice
Liu, Y., Akhter, M. P., Gao, X., Wang, X.-Y., Wang, X.-B., Zhao, G., Wei, X., Wu, H.-J., Chen, H., Wang, D., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s167431 · Cited by 53
Rydziel, S., Delany, A. M., & CANALIS, E. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311984200 · Cited by 52
Clinical and Basic Aspects of Glucocorticoid Action in Bone
Kream, B. E., Graves, L., & Lukert, B. P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00061-6 · Cited by 47
Glucocorticoid-Induced osteoporosis: clinical and therapeutic aspects
Mazziotti, G., Giustina, A., CANALIS, E. M., & Bilezikian, J. P. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800028 · Cited by 45
B cell acute lymphoblastic leukemia cells mediate RANK-RANKL–dependent bone destruction
Rajakumar, S. A., Papp, E., Lee, K. K., Grandal, I., Merico, D., Liu, C. C., Allo, B. A., Zhang, L., Grynpas, M. D., Minden, M. D., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aba5942 · Cited by 43
The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment
Oxlund, H., Ørtoft, G., Thomsen, J. S., Danielsen, C. C., Ejersted, C., & Andreassen, T. T. (2006) · Bone · doi:10.1016/j.bone.2006.01.142 · Cited by 43
Gender- and age-related differences in osteoclast formation from circulating precursors
Jevon, M., Sabokbar, A., Fujikawa, Y., HIRAYAMA, T., Neale, S. D., Wass, J. A. H., & Athanasou, N. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1720673 · Cited by 43
The molecular etiology and treatment of glucocorticoid-induced osteoporosis
Peng, C.-H., Lin, W.-Y., Yeh, K., Chen, I., Wu, W., & Lin, M. (2021) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_233_20 · Cited by 41
Lea, C. K., Sarma, U., & Flanagan, A. M. (1999) · Endocrinology · doi:10.1210/endo.140.1.6451 · Cited by 42
Glucocorticoids Regulate the Expression of the Human Osteoblastic Endothelin A Receptor Gene
Börcsök, I., Schairer, H. U., Sommer, U., Wakley, G. K., Schneider, U., Geiger, F., Niethard, F. U., Ziegler, R., & Kasperk, C. H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1563 · Cited by 38
Glucocorticoid-Induced Osteoporosis: A Review
Bouvard, B., Legrand, É., Audran, M., & Chappard, D. (2009) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-009-9051-9 · Cited by 37
Webster, J. M., Fenton, C. G., LANGEN, R. C. J., & Hardy, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225768 · Cited by 36
Ramli, E. S. M., Suhaimi, F., Asri, S. F. M., Ahmad, F., & Soelaiman, I. (2013) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-012-0413-x · Cited by 33
Reduced bone mineral density in male Severe Acute Respiratory Syndrome (SARS) patients in Hong Kong
Lau, E. M. C., Chan, F. W. K., Hui, D. S. C., Wu, A. K. L., & Leung, P. C. K. (2005) · Bone · doi:10.1016/j.bone.2005.04.018 · Cited by 31
Glucocorticoid-induced osteoporosis
de Gregório, L. H., Lacativa, P. G. S., Melazzi, A. C. C., & Russo, L. A. T. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000400024 · Cited by 30
Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations
Zhang, Y., & Milojevic, D. S. (2017) · Pediatric Drugs · doi:10.1007/s40272-017-0219-3 · Cited by 30
Osteoimmunology: Crosstalk Between T Cells and Osteoclasts in Osteoporosis
Lu, Z., Xiao, P., Liu, S., Huang, C., Li, W., Mao, Y., Xu, Y., & Tian, Y. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09046-1 · Cited by 34
Glucocorticoids and the risk of osteoporosis
Caplan, L., & Saag, K. G. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740330802648194 · Cited by 28
Short-term glucocorticoid treatment causes spinal osteoporosis in ovariectomized rats
Böcker, W., Khassawna, T. E., Bauer, N. B., Brodsky, K., Weisweiler, D., Govindarajan, P., Schlewitz, G., Kampschulte, M., Dürselen, L., Thormann, U., et al. (2014) · European Spine Journal · doi:10.1007/s00586-014-3463-z · Cited by 22
Kanekiyo, M., Itoh, N., Kawasaki, A., Matsuda, K., Nakanishi, T., & Tanaka, K. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10202 · Cited by 22
Williams, C. C., Trinh, H., Tran, T.-V., Dan, Q., Sanchez, R., Delgado, C., Chen, Y., Sippel, B., Jeffes, E. W. B., Wepsic, H. T., et al. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0253 · Cited by 21
Isaacs, S. D., Fan, X., Fan, D., Gewant, H. D., Murphy, T. C., FARMER, P. K., Taylor, W. R., Nanes, M. S., & Rubin, J. E. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199905)179:2 · Cited by 21
Self-citation11β-Hydroxysteroid Dehydrogenase, an Amplifier of Glucocorticoid Action in Osteoblasts
CANALIS, E. M., & Delany, A. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.987 · Cited by 20
Transcriptional regulation of the expression of macrophage colony stimulating factor
Rubin, J. E., Fan, D., Wade, A., Murphy, T. C., Gewant, H. D., Nanes, M. S., Fan, X., Moerenhout, M., & Hofstetter, W. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00212-9 · Cited by 20
Self-citationGlucocorticoid-induced osteoporosis: 2013 update
Mazzantini, M., & Munno, O. D. (2014) · Reumatismo · doi:10.4081/reumatismo.2014.787 · Cited by 19
Herath, M., Langdahl, B. L., Ebeling, P. R., & Milat, F. (2021) · Clinical Endocrinology · doi:10.1111/cen.14637 · Cited by 19
Chaweewannakorn, W., Ariyoshi, W., Okinaga, T., Morikawa, K., Saeki, K., Maki, K., & Nishihara, T. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.181 · Cited by 18
Stout, S. D., Cole, M. E., & Agnew, A. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809738-0.00006-5 · Cited by 21
Hu, Y., Lu, H., Fang, H., Chen, B., Chen, Z., Jiang, M., Zhou, Y., Li, Z., Gao, S., Huang, Z., et al. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002783 · Cited by 16
Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives
Altieri, B., Muscogiuri, G., Paschou, S. Α., Vryonidou, A., Casa, S. D., Pontecorvi, A., Faßnacht, M., Ronchi, C. L., & Newell-Price, J. D. C. (2018) · Endocrine · doi:10.1007/s12020-018-1696-z · Cited by 16
Corticosteroid-Induced Osteoporosis
Clarke, B. L. (2012) · American Journal of Clinical Dermatology · doi:10.2165/11594250-000000000-00000 · Cited by 16
Glucocorticoid-induced osteoporosis
CANALIS, E. M. (2000) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200012000-00005 · Cited by 16
Dexamethsone Suppresses Bone Formation via the Osteoclast
Kim, H., Zhao, H., Kitaura, H., Bhattacharyya, S., Brewer, J. A., Muglia, L. J., Ross, F. P., & Teitelbaum, S. L. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72009-8_5 · Cited by 15
Osteoporosis following heart transplantation and immunosuppressive therapy
Löfdahl, E., & Rådegran, G. (2017) · Transplantation Reviews · doi:10.1016/j.trre.2017.08.002 · Cited by 16
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros
Rossini, M., Orsolini, G., Viapiana, O., Adami, S., & Gatti, D. (2015) · Endocrine · doi:10.1007/s12020-014-0506-5 · Cited by 13
Increasing membrane-bound MCSF does not enhance OPGL-driven osteoclastogenesis from marrow cells
Fan, X., Fan, D., Gewant, H. D., Royce, C. L., Nanes, M. S., & Rubin, J. E. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.1.e103 · Cited by 13
Self-citationBone health in inflammatory bowel disease
Hao, W., Zhao, Y., & Xiang, L. (2023) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2023.2248874 · Cited by 13
Censi, S., Manso, J., Pandolfo, G., Franceschet, G., Cavedon, E., Zhu, Y. H., Carducci, S., Gomiero, W., Plebani, M., Zaninotto, M., et al. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0992-z · Cited by 11
Piper Sarmentosum: A New Hope for the Treatment of Osteoporosis
Ramli, E. S. M., Suhaimi, F. H., Ahmad, F., Shuid, A. N., Mohamad, N., & Soelaiman, I. N. (2013) · Current Drug Targets · doi:10.2174/13894501113146660228 · Cited by 11
Nakao, Y., Hikiji, H., Okinaga, T., Takeuchi, J., Habu, M., Yoshiga, D., Yoshioka, I., Nishihara, T., & Ariyoshi, W. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.137 · Cited by 10
Bone Tissue Engineering: Growth Factors and Cytokines
Hollinger, J. O., Srinivasan, A., Alvarez, P., Hsu, E., McBride, S., Eppell, S. J., Baskin, J. Z., Waters, H., & Gruber, R. (2011) · Comprehensive Biomaterials · doi:10.1016/b978-0-08-055294-1.00160-4 · Cited by 10
Chung, H.-Y., Kang, Y. S., Hwang, C. S., Moon, I. K., Yim, C. H., Choi, K. H., Han, K. O., Jang, H. C., Yoon, H. K., & Han, I. K. (2001) · Journal of Korean Medical Science · doi:10.3346/jkms.2001.16.6.769 · Cited by 10
Deng, P., Wang, Y., Shahbazian, V. L., & Pattengale, P. K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3423 · Cited by 7
Glucocorticoids and bone: cellular, metabolic and endocrine effects
Doga, M., Bonadonna, S., & Giustina, A. (2004) · HORMONES · doi:10.14310/horm.2002.11125 · Cited by 7
Henning, P., Conaway, H. H., & Lerner, U. H. (2022) · Vitamins and hormones · doi:10.1016/bs.vh.2022.04.005 · Cited by 8
The Cellular and Molecular Basis of Glucocorticoid Actions in Bone
Delany, A. M., Pereira, R. M. R., Pereira, R. C., & CANALIS, E. M. (2002) · KARGER eBooks · doi:10.1159/000061068 · Cited by 6
Glucocorticoid Regulation of Body Composition and Metabolism
Opata, A. A., Cheesman, K. C., & Geer, E. B. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_1 · Cited by 6
The Impact of Rheumatic Diseases and Their Treatment on Bone Strength Development in Childhood
Cimaz, R., & Ward, L. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24145-8.00053-3 · Cited by 5
Sarker, H., Hardy, E., Haimour, A., Karim, M. A., Scholl‐Bürgi, S., Martignetti, J. A., Botto, L. D., & Fernández-Patrón, C. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.568718 · Cited by 6
6.2 Bone Tissue Engineering: Growth Factors and Cytokines ☆
Hollinger, J. O., Alvarez, P., Ducheyne, P., Srinivasan, A., Baskin, J. Z., Waters, H., & Gruber, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803581-8.10205-x · Cited by 5
Glucocorticoids, Inflammation, and Bone
Ng, K. W., & Martin, T. J. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2745-1_7 · Cited by 4
Dan, Q., Trinh, H., Williams, C. C., Lloyd, C., Wepsic, H. T., Jeffes, E. W. B., & Jadus, M. R. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00007-8 · Cited by 4
Zhang, J., Dan, Q., Fong, T. C., Williams, C. C., Avina, M. D., Boldaji, M. T., Khalaghizadeh, S., Irwin, M. R., Nguyen, A., Zhuang, J., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.113 · Cited by 3
Bone health and cardiac transplantation
Löfdahl, E., Rådegran, G., & Fagher, K. (2022) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2022.101770 · Cited by 2
Glucocorticoids (as an Etiologic Factor)
Lee, E. Y., & Lee, Y. J. (2014) · Springer eBooks · doi:10.1007/978-3-642-35767-1_11 · Cited by 2
Effekte der Glukokortikoide auf den Knochen
Lang, A., Hoff, P. T., Buttgereit, F., & Amann, J. (2014) · Osteologie/Osteology · doi:10.1055/s-0037-1622016 · Cited by 2
Glucocorticoid-induced osteoporosis
Lau, A. N., Sambrook, P. N., & Adachi, J. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00202-3 · Cited by 2
Reid, I. R. (1999) · Journal of Intensive Care Medicine · doi:10.1177/088506669901400503 · Cited by 2
Bisphosphonates and implants in the jaw bone
Abtahi, J. (2013) · DiVA (Linkoping University) · Cited by 2
Hofstetter, W., & Gillespie, M. T. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50154-2 · Cited by 3
Pathological Mechanism of Glucocorticoid-induced Osteoporosis
Kim, H. J. (2009) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2009.24.4.231 · Cited by 1
Hofstetter, W. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00070-7 · Cited by 1
Glucocorticoid action in osteoblasts
Kido, S., 井上, 大., & 松本, 俊. (2004) · ホルモンと臨牀
Osteopontin and CSF-1 in bone resorption
Rittling, S. R. (2010) · Springer eBooks · doi:10.1007/978-4-431-99644-6_108
Fracture healing and glucocorticoids in HSD2 transgenic mouse model
Weber, A. J. (2012) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-16618
Metadata
- Authors
- Rubin, J., Biskobing, D. M., Jadhav, L., Fan, D., Nanes, M. S., Perkins, S., & Fan, X.
- Affiliations
- Emory University (US)
- University of Utah (US)
- Corresponding author
- Rubin, J.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1998-03
- Volume
- 139
- Issue
- 3
- Pages
- 1006-1012
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2080570046
- Cited by
- 113
- References
- 37
- Citations by year
- 2026: 1 · 2025: 3 · 2023: 2 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 2 · 2015: 5 · 2014: 7 · 2013: 4 · 2012: 5
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR42360)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
- Keywords
- dexamethasone, macrophage colony-stimulating factor, osteoclastogenesis, glucocorticoids, 1,25-dihydroxyvitamin D, osteoblast-like cells, ST2 cells, calvarial osteoblasts, osteoblasts, gene expression regulation, bone resorption
- MeSH terms
- Animals, Cells, Cultured, Dexamethasone, Dose-Response Relationship, Drug, Enzyme-Linked Immunosorbent Assay, Mice, Inbred C57BL, Osteoblasts, RNA, Messenger, Macrophage Colony-Stimulating Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review